Acrivon Therapeutics, Inc. - ACRV

Include option trades

Include indirect trades

EDGAR CIK

1 Month 3 Month 6 Month 1 Year 2 Years

Buy Breakdown

No sell transactions for this time period.

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
01/14/2026	01/16/2026	Blume-Jensen Peter President and CEO CEO Director	Buy	49,000 @ $1.68	$82,124.00	2,095,771	(2.39%)	Direct
01/14/2026	01/16/2026	Levy Adam D. Chief Financial Officer CFO	Buy	8,832 @ $1.70	$14,999.39	20,983	(72.69%)	Direct
01/13/2026	01/15/2026	Devroe Eric Chief Operating Officer Officer	Buy	10,000 @ $1.72	$17,218.00	75,308	(15.31%)	Direct